One is the classic treatment of esophageal cancer surgery, radiotherapy and chemotherapy, which is the classic treatment. Of course there are other adjuvant therapy, such as immunotherapy, and some Chinese medicine, this is only secondary, and we have a consciousness, not simply relying on traditional Chinese medicine can cure esophageal cancer, this concept may be a misunderstanding of.
It is reported: one is the treatment of esophageal classic surgery, radiotherapy and chemotherapy, which is the classic treatment. Of course there are other adjuvant therapy, such as immunotherapy, and some Chinese medicine, this is only secondary, and we have a consciousness, not simply relying on traditional Chinese medicine can cure esophageal cancer, this concept may be a misunderstanding of. Chinese only as an aid in regulating the immune function was good, so now, in China, Chinese traditional medicine, we can use, but the cancer can not rely on Chinese medicine.
From the choice, in the classic three methods of surgical treatment should be preferred, as long as they can be allowed to cut off cancer, and patients can afford this surgery, surgery should be preferred. Of course, such commitment to surgery and to surgery, these two concepts requires doctors have more experience, he was able to determine the depth of tumor invasion, the scope of what I can do surgery. I think this is very important. To patients after surgery, the patient's recovery also provides a very good condition. Overall, the survival rate of surgical treatment should be longer than the other.
Radiotherapy course is a partial cure, radiotherapy normal circumstances is through a direct rays to kill tumor cells, of course this case it also caused some destruction on the good cells. But generally if you do this tumor radiotherapy, radiotherapy only one cycle, for example to a certain dose, and next time will not be able to do, and if do, can be very serious complications, such as the consequences of radiation injury, the problem great.
Currently, through research, development, and chemotherapy drugs have a lot of progress, indeed, improve the efficacy of chemotherapy. However, there is a problem, first, chemotherapy is not 100% effective, because only part of the patient to be effective, this part of the patients is 30% to 40%. The remaining patients were not effective. Second, chemotherapy is a double-edged sword, on the good organization also has anti-role, so, in which case, the body can not withstand is a condition.
Now, some means is available, and how to improve the efficacy of chemotherapy, we can determine, such as chemotherapy drugs on the responsiveness of tumor cells, which is now allowed to do. This after his chemotherapy may be improved. Blindness is less than in the past.
Esophageal cancer has its particularity, such as liver and lungs are not the same. Not the same place because it is a digest of the pipeline, it is necessary to keep it smooth, but also to maintain its integrity. Once it's clear to die, the patient can not eat, if it undermines the integrity, it appears left out, so will bring about infection. Therefore, the overall treatment for the classic or current treatment of these methods. Of course, there are some palliative treatment, such as to solve the smooth Wen Ti, we take due to give him up a support, the stent into them, if possible, coupled with some of the treatment, such treatments may be on the quality of life of patients enhanced, because the patient first of all to eat, and then a good nutritional status, and physical strength, you can also do some further treatment. This is the case.
Of course, now there are some drugs you can try, such as targeted drug, now in the world are tentatively applied, also has some efficacy. Because of this targeted drug is now mainly used for lung cancer, esophageal cancer cases, but which also has a certain effect, which is also a way you can try.